Oxidative stress and diabetes mellitus

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 11, 2011, Pages 1773-1782

  Yang, Hui ^a   Jin, Xun ^a   Lam, Christopher Wai Kei ^b   Yan, Sheng Kai ^a,c  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^c Guang Zhou Improve Medical Instruments Co Ltd   (China)

Author keywords

Advanced glycation endproducts; Diabetes mellitus; Oxidative stress; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; ADENYLATE CYCLASE; ADVANCED GLYCATION END PRODUCT; ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; CARCINOGEN; DIACYLGLYCEROL; FORKHEAD TRANSCRIPTION FACTOR; GLUTATHIONE; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LIPID PEROXIDE; MACROPHAGE ACTIVATING FACTOR; MALONALDEHYDE; METABOTROPIC RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR BETA; UNCOUPLING PROTEIN; WNT PROTEIN;

APOPTOSIS; CELL DAMAGE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; IONIZING RADIATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENERGY METABOLISM; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 80755187946     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.250     Document Type: Review

References (83)

1. Maiese K, Morhan SD, Chong ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 2007;4:63-71. (Pubitemid 46280293)
2. Nielo VI, Fernandez VS, Alvaro C, Rondinone CM, Valverde AM, Lorenzo M. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 2007;56:404-13.
3. Chong ZZ, Maiese K. Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol 2004;19:495-504. (Pubitemid 38443910)
4. You Z, Saims D, Chen S, Zhang Z, Guttridge DC, Guan KL, et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 2002;157:429-40. (Pubitemid 34839807)
5. Farese RV, Sajan MP, Standaert ML. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med (Maywood) 2005;230:593-605. (Pubitemid 41506854)
6. Kenneth M, Zhao ZC, Yan CS. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem 2007;14: 1729-38.
7. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radical Bio Med 2003;34:1507-16. (Pubitemid 36638711)
8. Siu AW, To CH. Nitric oxide and hydroxyl radical-induced retinal lipid peroxidation in vitro. Clin Exp Optom 2002;85: 378-82.
9. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004;101:8491-6. (Pubitemid 38736602)
10. Greco A, Minghetti L. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases. Curr Neurovasc Res 2004;1:341-54.
11. Lee DH, O'Connor TR, Pfeifer GP. Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG-)TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells. Nucleic Acids Res 2002; 30:3566-73. (Pubitemid 34919212)
12. Adams S, Green P, Claxton R, Simcox S, Williams MV, Walsh K, et al. Reactive carbonyl formation by oxidative and nonoxidative pathways. Front Biosci 2001;6:A17-24.
13. Yamamoto T, Maruyama W, Kato Y, Yi H, Shamoto-Nagai M, Tanaka M, et al. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J Neural Transm 2002;109:1-13. (Pubitemid 34146585)
14. Tomiyama M, Furusawa K, Kamijo M, Kimura T, Matsunaga M, Baba M. Upregulation of mRNAs coding for AMPA and NMDA receptor subunits and metabotropic glutamate receptors in the dorsal horn of the spinal cord in a rat model of diabetes mellitus. Brain Res Mol Brain Res 2005;136:275-81. (Pubitemid 40704630)
15. Tong Q, Ouedraogo R, Kirchgessner AL. Localization and function of group III metabotropic glutamate receptors in rat pancreatic islets. Am J Physiol Endocrinol Metab 2002;282: E1324-33.
16. Nielo-Vazquez I, Fernandez-Veledo S, de Alvaro C, Rondinone CM, Valverde AM, Lorenzo M. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 2007;56:404-13.
17. Kang JQ, Chong ZZ, Maiese K. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol Pharmacol 2003;64:557-69. (Pubitemid 37048558)
18. Weber JT. Calcium homeostasis following traumatic neuronal injury. Curr Neurovasc Res 2004;1:151-71.
19. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004;279:42351-4.
20. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008;29:351-66. (Pubitemid 351679704)
21. Robertson RP, Zhang HJ, Pyzdrowski KL, Walseth TF. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 1992;90:320-5.
22. Olson LK, Redmon JB, Towle HC, Robertson RP. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest 1993;92:514-9. (Pubitemid 23209037)
23. Matsuoka TA, Zhao L, Artner I, Jarrett HW, Friedman D, Means A, et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol Cell Biol 2003;23:6049-62.
24. Harmon JS, Tanaka Y, Olson LK, Robertson RP. Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor- 1 partially restores insulin promoter activity. Diabetes 1998; 47:900-4. (Pubitemid 28255663)
25. Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, et al. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 1999;48:1230-6. (Pubitemid 29241019)
26. Harmon JS, Gleason CE, Tanaka Y, Oseid EA, Hunter-Berger KK, Robertson RP. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 1999;48:1995-2000. (Pubitemid 29458362)
27. Lu M, Seufert J, Habener JF. Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancerbinding protein beta. Inhibitory interactions with basic helixloop- helix transcription factor E47. J Biol Chem 1997;272: 28349-59.
28. Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, Perego C, et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 2001;50:1290-301. (Pubitemid 32500161)
29. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, et al. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001;50:1021-9.
30. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 1999;96:10857-62. (Pubitemid 29442234)
31. de la Monte SM, Chiche J, von dem Bussche A, Sanyal S, Lahousse SA, Janssens SP, et al. Nitric oxide synthase-3 overexpression causes apoptosis and impairs neuronal mitochondrial function: relevance to Alzheimer's-type neurodegeneration. Lab Invest 2003;83:287-98. (Pubitemid 36255372)
32. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pr 2001;53:33-9. (Pubitemid 32506898)
33. Kelpe CL, Moore PC, Parazzoli SD, Wicksteed B, Rhodes CJ, Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 2003;278:30015-21. (Pubitemid 36962391)
34. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-2. (Pubitemid 36583097)
35. Criscuolo F, Mozo J, Hurtaud C, Nubel T, Bouillaud F. UCP2, UCP3, avUCP, what do they do when proton transport is not stimulated? Possible relevance to pyruvate and glutamine metabolism. Biochim Biophys Acta 2006;1757:1284-91. (Pubitemid 44442133)
36. Douette P, Sluse FE. Mitochondrial uncoupling proteins: new insights from functional and proteomic studies. Free Radic Biol Med 2006;40:1097-107.
37. Li B, Nolte LA, Ju JS, Han DH, Coleman T, Holloszy JO, et al. Skeletal muscle respiratory uncoupling prevents dietinduced obesity and insulin resistance in mice. Nat Med 2000; 6:1115-20.
38. Li LX, Skorpen F, Egeberg K, Jorgensen IH, Grill V. Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal beta-cells. Biochem Biophys Res Commun 2001;282:273-7. (Pubitemid 32924375)
39. MacLellan JD, Gerrils MF, Gowing A, Smith PJ, Wheeler MB, Harper ME. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes 2005;54:2343-50. (Pubitemid 41134261)
40. Taniguchi S, Okinaka M, Tanigawa K, Miwa I. Difference in mechanism between glyceraldehyde- and glucose-induced insulin secretion from isolated rat pancreatic islets. J Biochem 2000;127:289-95. (Pubitemid 30136912)
41. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004;306:457-61. (Pubitemid 39372439)
42. Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka TA, et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem 2005;280: 847-51. (Pubitemid 40165054)
43. Tirosh A, Potashnik R, Bashan N, Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes: a putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 1999;274:10595-602.
44. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996;271:31372-8. (Pubitemid 26408588)
45. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, et al. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 2004;114: 928-36. (Pubitemid 39578720)
46. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004;304:1325-8. (Pubitemid 38697429)
47. Maiese K, Chong ZZ. Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. Restor Neurol Neurosci 2004;22:87-104. (Pubitemid 38850337)
48. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599-622. (Pubitemid 35191625)
49. Bhatia S, Shukla R, Venkata MS, Kaur GJ, Madhava PK. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003;36:557-62. (Pubitemid 37244019)
50. Sharma SK, Ebadi M. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons. Antioxid Redox Sign 2003;5:251-64. (Pubitemid 36793009)
51. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004;26:1044-80. (Pubitemid 39577337)
52. Pugazhenthi S, Nesterova A, Jambal P, Audesirk G, Kern M, Cabell L, et al. Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. J Neurochem 2003;84: 982-96. (Pubitemid 36330652)
53. Chong ZZ, Kang JQ, Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 2003;138:1107-18. (Pubitemid 36459833)
54. 2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J Neurosci Res 2003;72:508-19. (Pubitemid 36523425)
55. Chong ZZ, Kang JQ, Maiese K. Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J Cereb Blood Flow Metab 2003; 23:320-30. (Pubitemid 36307576)
56. Maiese K, Chong ZZ, Shang YC. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem 2007; 14:1729-38. (Pubitemid 47163410)
57. Ravichandran R, Shi FY, Ann MS. Methylglyoxal comes of age. Cell 2006;1:258-60.
58. Lapolla A, Reitano R, Seraglia R, Sartore G, Ragazzi E, Traldi P. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress. Mol Nutr Food Res 2005;49:685-90. (Pubitemid 41008206)
59. Yan SK. Methylglyoxal, oxidative stress and antioxidant status parameters in diabetic nephropathy. Chin Med J 2007:120 supplement 2:194-5.
60. El-ghoroury EA, Raslan HM, Badawy EA, El-Saaid GS, Agybi MH, Siam I, et al. Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control. Blood Coagul Fibrinolysis 2009;20:248-51.
61. Vosough-Ghanbari S, Rahimi R, Kharabaf S, Zeinali S, Mohammadirad A, Amini S, et al. Effects of Satureja khuzestanica on serum glucose, lipids and markers of oxidative stress in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial. Evid Based Complement Alternat Med 2010;7:465-70.
62. Burnett AL, Strong TD, Trock BJ, Jin L, Bivalacqua TJ, Musicki B. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2diabetic men with erectile dysfunction. J Urol 2009;181: 245-51.
63. Kaviarasan S, Muniandy S, Qvist R, Ismail IS. F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review. J Clin Biochem Nutr 2009;45:1-8.
64. Flores L, Rodela S, Abian J, Clària J, Esmatjes E. F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control. Metabolism 2004;53:1118-20. (Pubitemid 39140743)
65. Kostolanska J, Jakus V, Barak L. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2009;22:433-42.
66. Hernandez-Marco R, Codoner-Franch P, Pons Morales S, Del Castillo Villaescusa C, Boix Garcia L, Valls Bellés V. Oxidant/ antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr Nephrol 2009;24:121-7.
67. Sell DR, Strauch CM, Shen W, Monnier VM. 2-Aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem J 2007;404:269-77. (Pubitemid 46849598)
68. Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, et al. Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 2001;24:733-7. (Pubitemid 32888856)
69. Al-Aubaidy HA, Jelinek HF. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep 2010;15:155-60.
70. Miller NJ, Rice-Evans CA. Factors influencing the antioxidant activity determined by the ABTSq radical cation assay. Free Radical Res 1997;26:195-9. (Pubitemid 27187035)
71. Talegawkar SA, Beretta G, Yeum KJ, Johnson EJ, Carithers TC, Taylor HA Jr., et al. Total antioxidant performance is associated with diet and serum antioxidants in participants of the diet and physical activity substudy of the Jackson Heart Study. J Nutr 2009;139:1964-71.
72. Szeto YT, Benzie IF. Total antioxidant power and ascorbic acid content of aqueous extracts of fresh fruits and vegetables: implications for dietary planning and food preservation. Br J Nutr 2002;87:55-9. (Pubitemid 34116442)
73. Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res 2008;638:98-102.
74. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophy Acta 1987;924:408-19.
75. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet 2008;21:9-30.
76. Gehrmann W, Elsner M, Lenzen S. Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic bcells. Diabetes Obes Metab 2010;12:149-58.
77. De Mattia G, Bravi MC, Laurenti O, Moretti A, Cipriani R, Gatti A, et al. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications. Diabetes Res Clin Pr 2008;79:337-42.
78. Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci 2008;65:71-4. (Pubitemid 351913978)
79. Robertson RP. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy. Discov Med 2010;9:132-7.
80. Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, et al. Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett 2000;473:24-6. (Pubitemid 30235178)
81. Kimoto K, Suzuki K, Kizaki T, Hitomi Y, Ishida H, Katsuta H, et al. Gliclazide protects pancreatic beta-cells from damage by hydrogen peroxide. Biochem Biophys Res Commun 2003;303: 112-9. (Pubitemid 36338215)
82. Vassort G, Turan B. Protective role of antioxidants in diabetesinduced cardiac dysfunction. Cardiovasc Toxicol 2010;10:73- 86.
83. Scott JA, King GL. Oxidative stress and antioxidant treatment in diabetes. Ann NY Acad Sci 2004;1031:204-13. (Pubitemid 40361755)